VivoSim Labs, INC. (VIVS) stock
VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.12−0.00 (-2.91%)
Close on Nov 17, 2026Market cap $383.64KP/E –Yield –
VivoSim Labs enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
VivoSim Labs's enterprise value was -$1.18M on Nov 11, 2026, against -$835.17K a year earlier. Over the last 5 years it ranged from -$13.26M to $9.98M, with a median of -$739.18K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.18M | – |
| 2025 | Dec 31, 2025 | -$1.96M | -150.3% |
| 2024 | Dec 31, 2024 | $3.89M | +88.8% |
| 2023 | Dec 29, 2023 | $2.06M | – |
| 2022 | Dec 30, 2022 | -$10.93M | – |
| 2021 | Dec 31, 2021 | -$2.19M | -103.4% |
| 2020 | Dec 31, 2020 | $65.15M | +292.3% |
| 2019 | Dec 31, 2019 | $16.61M | -77.3% |
| 2018 | Dec 31, 2018 | $73.24M | -20.8% |
| 2017 | Dec 29, 2017 | $92.53M | -65.2% |
| 2016 | Dec 30, 2016 | $266.11M | +73.9% |
| 2015 | Dec 31, 2015 | $153.03M | -71.0% |
| 2014 | Dec 31, 2014 | $528.54M | -16.5% |
| 2013 | Dec 31, 2013 | $633.17M | +1149.3% |
| 2012 | Dec 31, 2012 | $50.68M | – |
See a number that looks wrong?